Bleeding Complication of Triple Therapy of Rivaroxaban, Prasugrel, and Aspirin: A Case Report and General Discussion
Hemorrhagic side effects are the bane of oral anticoagulation. Despite careful selection of medications and close monitoring, some adverse events are unavoidable. The available literature about the risks of triple oral anticoagulation therapy versus dual antiplatelet therapy does not address all of...
Main Authors: | Dane D. Gruenebaum, Ahmad Alsarah, Osama Alsara, Heather Laird-Fick |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2014-01-01
|
Series: | Case Reports in Cardiology |
Online Access: | http://dx.doi.org/10.1155/2014/293476 |
Similar Items
-
Cardiac manifestations of Familial Mediterranean fever
by: Ahmad Alsarah, et al.
Published: (2017-10-01) -
Isolated Left Main Coronary Artery Stenosis after Thoracic Radiation Therapy: To Operate or Not to Operate
by: Osama Alsara, et al.
Published: (2013-01-01) -
Bleeding risks with novel oral anticoagulants especially rivaroxaban versus aspirin: a meta-analysis
by: Xiehui Chen, et al.
Published: (2021-10-01) -
Hypertension management in older adults
by: Ahmad Alsarah, et al.
Published: (2018-04-01) -
Hypertension management in the elderly: What is the optimal target blood pressure?
by: Ahmad Alsarah, et al.
Published: (2019-01-01)